Ingersoll Rand Outlook - A Cautionary Technical Signal Amid Mixed Analyst Opinions

1. Market Snapshot

Takeaway: Ingersoll Rand (IR) is currently experiencing a weak technical outlook and a mixed analyst consensus, suggesting a cautious stance for investors.

The stock has seen a recent price drop of -0.81%, and our internal diagnostic score (0-10) for technical strength stands at 2.11. Analyst ratings are split between "Buy" and "Neutral", with an average rating score of 3.50 and a performance-weighted score of 3.33.

2. News Highlights

Recent headlines include changes to U.S. vaccine policy, which could indirectly affect industries reliant on workforce health and safety protocols. Additionally, China's factory activity, though still contracting, showed signs of improvement in May. These global developments may influence Ingersoll Rand's operating environment in the mid to long-term.

3. Analyst Views & Fundamentals

Analysts have issued four recent ratings over the last 20 days, with two "Buy" and two "Neutral" recommendations. The average rating score is 3.50, while the performance-weighted score is 3.33. These scores show some alignment with the current price trend, but the recent price drop suggests a lack of strong conviction from the market.

• EV/EBIT: 148.57 - Internal diagnostic score: 1.00
• PE: -143.27 - Internal diagnostic score: 1.00
• Basic EPS YoY growth: -81.25% - Internal diagnostic score: 0.00
• Current assets turnover: 86.32% - Internal diagnostic score: 1.00
• Cash to Market Value: -32.31% - Internal diagnostic score: 2.00

4. Money-Flow Trends

Money is flowing into Ingersoll Rand, particularly from institutional investors. The internal diagnostic score for fund flow is 7.95, indicating positive big-money inflows. Large and extra-large investors are particularly active, contributing to the positive trend. Meanwhile, retail investors show a more mixed approach, with small investors trending negatively.

5. Key Technical Signals

Three recent technical indicators have emerged as critical to Ingersoll Rand’s chart:

• Williams %R Overbought - Internal diagnostic score: 2.18
• Williams %R Oversold - Internal diagnostic score: 3.15
• Dividend Payable Date - Internal diagnostic score: 1.00

Key dates with new signals include August 26, September 2, September 3, and September 5, where both overbought and oversold conditions were recorded. The overall technical analysis suggests weak momentum, with three bearish signals and no bullish ones in the last five days.

6. Conclusion

Given the internal diagnostic score (0-10) of 2.11 for technical strength and the current bearish momentum, investors may want to consider holding off on new positions in Ingersoll Rand for now. However, the positive fund flow trend and mixed analyst opinions could signal a potential turning point if fundamentals show improvement.

Consider waiting for a pull-back or clearer technical signals before deciding to enter the stock.